BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heise T, Büll C, Beurskens DM, Rossing E, de Jonge MI, Adema GJ, Boltje TJ, Langereis JD. Metabolic Oligosaccharide Engineering with Alkyne Sialic Acids Confers Neuraminidase Resistance and Inhibits Influenza Reproduction. Bioconjug Chem 2017;28:1811-5. [PMID: 28635265 DOI: 10.1021/acs.bioconjchem.7b00224] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gilormini PA, Lion C, Vicogne D, Guérardel Y, Foulquier F, Biot C. Chemical glycomics enrichment: imaging the recycling of sialic acid in living cells. J Inherit Metab Dis 2018;41:515-23. [PMID: 29294191 DOI: 10.1007/s10545-017-0118-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Blundell PA, Lu D, Wilkinson M, Dell A, Haslam S, Pleass RJ. Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers with Glycan-Dependent Receptors and Blocks Hemagglutination by the Influenza Virus. J Immunol 2019;202:1595-611. [PMID: 30683699 DOI: 10.4049/jimmunol.1801337] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
3 Moons SJ, Adema GJ, Derks MT, Boltje TJ, Büll C. Sialic acid glycoengineering using N-acetylmannosamine and sialic acid analogs. Glycobiology 2019;29:433-45. [PMID: 30913290 DOI: 10.1093/glycob/cwz026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Banahene N, Kavunja HW, Swarts BM. Chemical Reporters for Bacterial Glycans: Development and Applications. Chem Rev 2021. [PMID: 34905344 DOI: 10.1021/acs.chemrev.1c00729] [Reference Citation Analysis]
5 Yuan L, Zhao Y, Sun XL. Sialidase substrates for Sialdiase assays - activity, specificity, quantification and inhibition. Glycoconj J 2020;37:513-31. [PMID: 32813176 DOI: 10.1007/s10719-020-09940-0] [Reference Citation Analysis]
6 Chinoy ZS, Montembault E, Moremen KW, Royou A, Friscourt F. Impacting Bacterial Sialidase Activity by Incorporating Bioorthogonal Chemical Reporters onto Mammalian Cell-Surface Sialosides. ACS Chem Biol 2021;16:2307-14. [PMID: 34590826 DOI: 10.1021/acschembio.1c00469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bi X, Yin J, Chen guanbang A, Liu C. Chemical and Enzymatic Strategies for Bacterial and Mammalian Cell Surface Engineering. Chem Eur J 2018;24:8042-50. [DOI: 10.1002/chem.201705049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
8 Heise T, Langereis JD, Rossing E, de Jonge MI, Adema GJ, Büll C, Boltje TJ. Selective Inhibition of Sialic Acid-Based Molecular Mimicry in Haemophilus influenzae Abrogates Serum Resistance. Cell Chem Biol 2018;25:1279-1285.e8. [PMID: 29983272 DOI: 10.1016/j.chembiol.2018.05.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
9 Ghirardello M, Shyam R, Galan MC. Reengineering of cancer cell surface charges can modulate cell migration. Chem Commun (Camb) 2022;58:5522-5. [PMID: 35420600 DOI: 10.1039/d2cc00402j] [Reference Citation Analysis]
10 Glanz VY, Myasoedova VA, Grechko AV, Orekhov AN. Sialidase activity in human pathologies. Eur J Pharmacol 2019;842:345-50. [PMID: 30439363 DOI: 10.1016/j.ejphar.2018.11.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
11 Critcher M, O'leary T, Huang ML. Glycoengineering: scratching the surface. Biochemical Journal 2021;478:703-19. [DOI: 10.1042/bcj20200612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
12 [DOI: 10.1101/2020.09.15.288712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Lu W, Pieters RJ. Carbohydrate–protein interactions and multivalency: implications for the inhibition of influenza A virus infections. Expert Opinion on Drug Discovery 2019;14:387-95. [DOI: 10.1080/17460441.2019.1573813] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]